Technical Analysis for CLSD - Clearside Biomedical, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Calm After Storm | Range Contraction | -8.77% | |
NR7 | Range Contraction | -8.77% | |
Upper Bollinger Band Walk | Strength | -8.77% | |
Inside Day | Range Contraction | -8.77% | |
Wide Bands | Range Expansion | -8.77% | |
Calm After Storm | Range Contraction | -9.83% | |
Upper Bollinger Band Walk | Strength | -9.83% |
Alert | Time |
---|---|
Reversed from Down | about 18 hours ago |
2x Volume Pace | about 18 hours ago |
1.5x Volume Pace | about 18 hours ago |
3x Volume Pace | about 18 hours ago |
10x Volume Pace | about 18 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/07/2024
Clearside BioMedical, Inc., a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Eye Ophthalmology Macular Degeneration Macular Edema Retina Veins Wet Age Related Macular Degeneration Drug Therapies Uveitis Adverum Biotechnologies Non Infectious Uveitis Retinal Vein Occlusion
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Eye Ophthalmology Macular Degeneration Macular Edema Retina Veins Wet Age Related Macular Degeneration Drug Therapies Uveitis Adverum Biotechnologies Non Infectious Uveitis Retinal Vein Occlusion
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.12 |
52 Week Low | 0.6501 |
Average Volume | 347,337 |
200-Day Moving Average | 1.12 |
50-Day Moving Average | 1.40 |
20-Day Moving Average | 1.51 |
10-Day Moving Average | 1.65 |
Average True Range | 0.20 |
RSI (14) | 52.61 |
ADX | 34.03 |
+DI | 18.98 |
-DI | 12.58 |
Chandelier Exit (Long, 3 ATRs) | 1.53 |
Chandelier Exit (Short, 3 ATRs) | 1.76 |
Upper Bollinger Bands | 1.88 |
Lower Bollinger Band | 1.14 |
Percent B (%b) | 0.57 |
BandWidth | 49.24 |
MACD Line | 0.10 |
MACD Signal Line | 0.09 |
MACD Histogram | 0.0094 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.99 | ||||
Resistance 3 (R3) | 2.02 | 1.90 | 1.92 | ||
Resistance 2 (R2) | 1.90 | 1.79 | 1.89 | 1.90 | |
Resistance 1 (R1) | 1.73 | 1.72 | 1.67 | 1.70 | 1.87 |
Pivot Point | 1.61 | 1.61 | 1.58 | 1.60 | 1.61 |
Support 1 (S1) | 1.44 | 1.50 | 1.38 | 1.42 | 1.25 |
Support 2 (S2) | 1.32 | 1.43 | 1.31 | 1.22 | |
Support 3 (S3) | 1.15 | 1.32 | 1.20 | ||
Support 4 (S4) | 1.13 |